SB 899 Pennsylvania Senate · 2025-2026 Regular Session

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

SB 899 amends the state's Controlled Substance Act to update the schedules of controlled substances, classifying specific drugs into categories based on their medical use and potential for abuse. It directly affects pharmacies, healthcare providers, law enforcement, and patients who handle or prescribe these substances by changing their legal classifications. The bill's key mechanism involves modifying the existing schedule lists to reflect current medical knowledge and drug usage patterns, without adding new penalties or creating new regulatory requirements. This update ensures the scheduling framework aligns with current scientific understanding and medical practice.
Bill status in committee 1 of 4 stages cleared
Introduction
Jun 2025
Committee Review
Floor Vote
Governor
Introduced Jun 30, 2025 Last action Mar 23, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Printer's No. PN1029 Printer's No. PN1319 · 4 edits
MODERATE
This bill version expands the scope of kratom regulations by adding a new prohibition on selling kratom products to minors under specific unsafe conditions, such as improper labeling or mixing with other substances. It also updates the legal penalties for violating these rules and formally adds kratom alkaloids to the state's Schedule I list of controlled substances.
Scope change
The bill now explicitly covers the sale of kratom to minors and includes specific chemical definitions for Schedule I controlled substances.
REQUIREMENT

Added a new prohibition preventing the sale of kratom products to minors if the product is mixed, lacks adequate labeling, or does not include a recommended serving size.

ENFORCEMENT

Established criminal penalties for violating the new kratom sale restrictions, with stricter misdemeanor charges for processors compared to other retailers.

DEFINITION

Added specific legal definitions for Schedule I controlled substances, including 7-hydroxymitragynine and other synthetic forms of mitragynine.

ELIGIBILITY

Updated the list of bill sponsors to include new legislators (Flynn, Laughlin, Miller) and added Senator Brooks to the referral list.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
5
Key actions
1
Committee
1
Amendments
1
Nov 18, 2025
Upper · Passed
Reported as amended
upper
Jun 30, 2025
Committee
Referred to Health & Human Services
upper
1 primary · 11 co-sponsors

Sponsors